Andersons pediatric cardiology 152

detailsofmembranesystemsforCa2+signaling
intheheart.JCellSci.2009;122:1005–1013.
219.BersDM.Cardiacsarcoplasmicreticulum
calciumleak:Basisandrolesincardiac
dysfunction.AnnuRevPhysiol.2014;76:107–
127.
220.Franzini-ArmstrongC,ProtasiF,TijskensP.The
assemblyofcalciumreleaseunitsincardiac
muscle.AnnNYAcadSci.2005;1047:76–85.
221.NassarR,ReedyMC,AndersonPA.
Developmentalchangesintheultrastructureand
sarcomereshorteningoftheisolatedrabbit
ventricularmyocyte.CircRes.1987;61:465–
483.
222.YamakawaH,MurataM,SuzukiT,etal.
Suppressionofradleadstoarrhythmogenesisvia
PKA-mediatedphosphorylationofryanodine
receptoractivityintheheart.BiochemBiophys
ResCommun.2014;452:701–707.
223.HarveyRD,HellJW.CaV1.2signaling
complexesintheheart.JMolCellCardiol.
2013;58:143–152.
224.TeareD.Asymmetricalhypertrophyoftheheart
inyoungadults.BrHeartJ.1958;20:1–8.
225.HoustonBA,StevensGR.Hypertrophic
cardiomyopathy:Areview.ClinMedInsights
Cardiol.2014;8:53–65.


226.Sen-ChowdhryS,JacobyD,MoonJC,McKenna
WJ.Updateonhypertrophiccardiomyopathy

andaguidetotheguidelines.NatRevCardiol.
2016;13:651–675.
227.MaronBJ,OmmenSR,SemsarianC,etal.
Hypertrophiccardiomyopathy:Presentand
future,withtranslationintocontemporary
cardiovascularmedicine.JAmCollCardiol.
2014;64:83–99.
228.MaronBJ,RowinEJ,CaseySA,etal.
Hypertrophiccardiomyopathyinchildren,
adolescents,andyoungadultsassociatedwith
lowcardiovascularmortalitywithcontemporary
managementstrategies.Circulation.
2016;133:62–73.
229.Aartsma-RusA,GinjaarIB,BushbyK.The
importanceofgeneticdiagnosisforDuchenne
musculardystrophy.JMedGenet.2016;53:145–
151.
230.BushbyK,FinkelR,BirnkrantDJ,etal.
DiagnosisandmanagementofDuchenne
musculardystrophy,part1:Diagnosis,and
pharmacologicalandpsychosocialmanagement.
LancetNeurol.2010;9:77–93.
231.MercuriE,MuntoniF.Musculardystrophies.
Lancet.2013;381:845–860.
232.BladenCL,SalgadoD,MongesS,etal.The


TREAT-NMDDMDGlobalDatabase:Analysis
ofmorethan7,000Duchennemuscular
dystrophymutations.HumMutat.2015;36:395–

402.
233.DeconinckN,DanB.Pathophysiologyof
Duchennemusculardystrophy:Current
hypotheses.PediatrNeurol.2007;36:1–7.
234.vanWesteringTL,BettsCA,WoodMJ.Current
understandingofmolecularpathologyand
treatmentofcardiomyopathyinDuchenne
musculardystrophy.Molecules.2015;20:8823–
8855.
235.BoussaidG,LofasoF,SantosDB,etal.Impact
ofinvasiveventilationonsurvivalwhennoninvasiveventilationisineffectiveinpatients
withDuchennemusculardystrophy:A
prospectivecohort.RespirMed.2016;115:26–
32.
236.BirnkrantDJ,AraratE,MhannaMJ.Cardiac
phenotypedeterminessurvivalinDuchenne
musculardystrophy.PediatrPulmonol.
2016;51:70–76.
237.PassamanoL,TagliaA,PalladinoA,etal.
ImprovementofsurvivalinDuchennemuscular
dystrophy:Retrospectiveanalysisof835
patients.ActaMyol.2012;31:121–125.
238.PunnooseAR,KaltmanJR,PastorW,etal.